NCT02157116View on ClinicalTrials.gov

Dose-Dense Induction/Neoadjuvant Chemotherapy in Locally Advanced Non-Small Cell Lung Cancer

PHASE2TerminatedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

October 31, 2009

Study Completion Date

January 31, 2010

Conditions
Non-small Cell Lung Cancer
Interventions
DRUG

cisplatin

DRUG

Docetaxel

DRUG

Pegfilgrastim

Trial Locations (1)

27710

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

Duke University

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Duke University

OTHER